CONSTIPATION IN ICU
1. DEFINITION (No universal consensus)
Most ICU studies define constipation as:
- No bowel movement for ≥3 days
- OR need for rescue laxatives/enema
- OR hard stools / difficult evacuation
Table of Contents
Toggle2. EPIDEMIOLOGY
- Incidence: 15–83% (very common in ICU)
- Higher in:
- Mechanically ventilated patients
- Sedated/paralyzed patients
- Opioid use
- Enteral feeding patients
3. WHY IT MATTERS
Constipation leads to:
A. Gastrointestinal effects
- Ileus
- Abdominal distension
- Increased intra-abdominal pressure (IAP)
- Feeding intolerance → ↑ aspiration risk
- Vomiting
- Nutritional Failure
- Anal fissure
B. Respiratory effects
- Diaphragmatic splinting → difficult weaning
- ↑ ventilator days
C. Systemic effects
- Bacterial translocation → sepsis risk (theoretical)
- Delirium (gut-brain axis)
4. PATHOPHYSIOLOGY (MULTIFACTORIAL)
A. Reduced gut motility
- Critical illness → autonomic dysfunction
- ↓ parasympathetic tone
B. Medications (most important cause)
- Opioids → μ-receptor mediated ↓ peristalsis
- Sedatives (propofol, benzodiazepines)
- Anticholinergics
- Vasopressors → ↓ splanchnic perfusion
C. Electrolyte imbalance
- Hypokalemia → ↓ smooth muscle contractility
- Hypercalcemia → constipation
D. Immobility
- Bed rest → ↓ colonic motility
E. Enteral feeding issues
- Low fiber feeds
- Inadequate hydration
5. RISK FACTORS
|
Category |
Risk Factors |
|
Drugs |
|
|
Electrolytes |
Hypokalemia, hypercalcemia,Hypomagnesemia |
|
ICU factors |
Mechanical ventilation, sedation |
|
Nutrition |
Low fiber, inadequate fluids |
|
Neurologic |
Stroke, spinal cord injury |
6. DIAGNOSIS
A. History
- Last bowel movement
- Stool consistency
- Laxative use
B. Examination
- Abdominal distension(then Do X-ray abdomen)
- Bowel sounds
- Rectal exam → fecal impaction
C. Monitoring tools
- Daily bowel chart (essential in ICU)
D. Investigations (if needed)
- X-ray abdomen → fecal loading / ileus
- CT abdomen → obstruction (if suspected)
7. DIFFERENTIAL DIAGNOSIS
|
Condition |
Key Difference |
|
Paralytic ileus |
Absent bowel sounds, diffuse dilation |
|
Mechanical obstruction |
Colicky pain, air-fluid levels |
|
Ogilvie syndrome (ACPO) |
Massive colonic dilation (cecum >10–12 cm) |
|
Fecal impaction |
Hard stool in rectum |
8. MANAGEMENT
- No bowel movement is not an emergency. There is no absolute requirement for one bowel movement daily. (Normal frequency ranges from ~3/week to 3/day.)
- Escalate therapy gradually and early rather than using multiple laxatives at once.
- Most laxatives require 12–24 hours (or longer) to become effective.
- Avoid rapid escalation within the first 24 hours, as this increases the risk of diarrhea, electrolyte disturbances, and fecal incontinence.
- Reassess bowel function daily and escalate only if there is no response.
FIRST RULE: RULE OUT SURGICAL CAUSES
Before treating “constipation,” exclude:
- Mechanical bowel obstruction
- Paralytic ileus
- Acute colonic pseudo-obstruction (Ogilvie)
Clues:
- Severe distension
- Vomiting
- Absent bowel sounds
- Cecum >10–12 cm (X-ray)
CORRECT REVERSIBLE CAUSES
A. Drug review (MOST IMPORTANT)
- Reduce/stop:
- Opioids (if possible)
- Anticholinergics
- Sedatives
If opioids required → plan early PAMORA
B. Correct metabolic abnormalities
- Hypokalemia → target K⁺ >4 mEq/L
- Hypercalcemia → treat cause
- Hypomagnesemia
C. Optimize perfusion
- Avoid excessive vasopressors
- Ensure adequate splanchnic perfusion
D. Hydration
- Intubated patients: Free water flushes, ~1 liter/day.
- Avoid dehydration (especially in enteral feeds)
NON-PHARMACOLOGICAL MANAGEMENT
A. Early enteral nutrition (VERY IMPORTANT)
- Stimulates gut motility via:Gastrocolic reflex
- Preferred over parenteral nutrition
B. Soluble Fiber-10-20 grams
- Exp- Guar gum
- Use only if no ileus
- Avoid in:
- Severe sepsis
- Gut hypoperfusion
C. Mobilization
- Even passive limb movement helps
D. Bowel charting
- Daily documentation:
- Stool frequency
- Consistency
PHARMACOLOGICAL MANAGEMENT
A. OSMOTIC LAXATIVES (FIRST-LINE)
|
Osmotic Laxative |
Dose |
|
Polyethylene Glycol (PEG) Powder |
Dose: 17–34 g/day PO or via NG tube. onset~24-48 hours Mechanism: Non-absorbable osmotic agent that retains water in the intestinal lumen, increasing stool water content and promoting bowel movements. Advantages:Preferred osmotic laxative in many ICU patients; causes less bloating and gas than lactulose, is generally better tolerated, and has minimal electrolyte absorption. |
|
Lactulose |
Dose: 15–30 mL PO/NG two to three times daily (BD–TDS), titrated to the desired bowel movement frequency. Mechanism: Fermented by colonic bacteria into organic acids, producing an osmotic effectand acidifying the colonic lumen, which also promotes conversion of ammonia (NH₃) to ammonium (NH₄⁺). Disadvantages: Bloating, abdominal distension, flatulence, diarrhea, and potential electrolyte disturbances with excessive use.Not Preferred |
B. STIMULANT LAXATIVES (ADD-ON)
Used if osmotic laxatives inadequate
|
Stimulant Laxative |
Dose |
|
Bisacodyl |
Dose: 5–10 mg PO or 10 mg rectal suppository once daily as needed. Mechanism: Directly stimulates the enteric nerves of the colon, increasing colonic peristalsis and promoting fluid secretion.contraindications-Rectal impaction,Mechanical bowel obstruction, toxic megacolon.Side effects-Abdominal cramping,Diarrhea. Preferred over Senna |
|
Senna (Sennosides) |
Dose: 15 mg PO once daily (titrate to ~100 mg/day(Max)). Mechanism: Stimulant laxative that is converted by colonic bacteria into active metabolites, increasing colonic motility and fluid secretion. |
C. STOOL SOFTENERS
- Docusate sodium
Limited ICU evidence → not preferred alone
D.Milk of Magnesia(magnesium hydroxide)
- Contraindicated in renal failure (GFR <20-30 ml/min)
E. RECTAL THERAPY (ESCALATION)
Manual disimpaction
- For fecal impaction
- Requires lubrication + analgesia
Enemas
Enemas are generally not preferred.
Indications:
- Suspected distal stool retention and you want to avoid digital disimpaction.
- Spinal cord injury causing a lack of rectal sensation
Contraindications to Enemas
- Inability to retain or expel the enema (e.g., severe altered mental status, significant neurologic dysfunction, absent rectal control).
- Sodium phosphate enemas: Avoid in CKD/AKI or significant renal dysfunction due to the risk of severe hyperphosphatemia, hypocalcemia, and acute phosphate nephropathy.
- Suspected colonic perforation or high perforation risk, e.g., toxic megacolon, fulminant colitis, or severe acute colonic inflammation.
⚠️ Also avoid/use extreme caution in suspected bowel obstruction, recent colorectal surgery, severe neutropenia/thrombocytopenia (risk of mucosal injury), or severe anorectal disease (e.g., painful fissure, severe hemorrhoids).
Other Options:
- Glycerin suppository
- Bisacodyl suppository
PROKINETIC AGENTS (IF ILEUS COMPONENT)
1. Metoclopramide
- Dose:10 mg IV TDS
- Action:Dopamine antagonist → ↑ gastric emptying
2. Erythromycin
- Dose:200 mg IV BD
- Mechanism:Motilin receptor agonist
Useful in:
- Feed intolerance
- Gastroparesis
OPIOID-INDUCED CONSTIPATION
Pathophysiology:
- μ-receptor activation → ↓ peristalsis + ↑ absorption
Treatment: PAMORAs (Peripheral μ-opioid receptor antagonists)
Do NOT reverse analgesia add non-opioid analgesic (e.g., pain-dose ketamine).
1. Enteral naloxone
- Dose:4-8 mg enteral naloxone via feeding tube, every six hours if needed
2. Methylnaltrexone was ineffective in the MOTION trial.
REFERENCES
- Irwin and Rippe’s Intensive Care Medicine
- Sayuk GS, Yu QT, Shy C. Management of Constipation in Hospitalized Patients. J Clin Med. 2023 Sep 23;12(19):6148. doi: 10.3390/jcm12196148. PMID: 37834791; PMCID: PMC10573544.
